BIOFORCE NANOSCIENCES HOLDINGS, INC. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bioforce Nanosciences Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Bioforce Nanosciences Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was 24.1 %, a 22.1% decline year-over-year.
  • Bioforce Nanosciences Holdings, Inc. annual Return On Equity for 2023 was 28.6 %, a 30.9% decline from 2022.
  • Bioforce Nanosciences Holdings, Inc. annual Return On Equity for 2022 was 41.5 %, a 43.5% decline from 2021.
  • Bioforce Nanosciences Holdings, Inc. annual Return On Equity for 2021 was 73.4 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 28.6 -12.8 -30.9% Jan 1, 2023 Dec 31, 2023
2022 41.5 -31.9 -43.5% Jan 1, 2022 Dec 31, 2022
2021 73.4 -89.2K Jan 1, 2021 Dec 31, 2021
2020 89.3K* +89.4K Jan 1, 2020 Dec 31, 2020
2019 -108 +214 +66.3% Jan 1, 2019 Dec 31, 2019
2018 -322 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.